Related Experiment Video
Updated: May 31, 2026
08:53
Synthesis, Functionalization, and Characterization of Fusogenic Porous Silicon Nanoparticles for Oligonucleotide Delivery
Published on: April 16, 2019
Self-assembled multifunctional nanoplexes for gene inhibitory therapy
Fereshteh Azari1, Marinella G Sandros, Maryam Tabrizian
1Department of Biomedical Engineering, McGill University, 3775 University Street, Montreal, Quebec, H3A2B4, Canada.
Nanomedicine (London, England)
|July 2, 2011
Summary
A novel nanoplex system enhances siRNA stability and delivery. Histidylated glycol chitosan (GC-His) nanoplexes improved siRNA uptake and reduced MDM2 protein expression, showing promise for gene therapy.
Area of Science:
- Biotechnology
- Nanomedicine
- Gene Therapy
Background:
- Small interfering RNA (siRNA) offers therapeutic potential but faces challenges in stability and targeted delivery.
- Developing effective delivery vehicles is crucial for successful siRNA-based therapies.
- Visualization of siRNA at the target site can improve treatment monitoring.
Purpose of the Study:
- To develop a novel nanoplex system for enhanced siRNA stability and therapeutic efficacy.
- To improve the visualization of siRNA delivery to target sites.
- To evaluate the performance of the developed nanoplex system in gene silencing.
Main Methods:
- Functionalization of siRNA with near-infrared quantum dots.
- Encapsulation of functionalized siRNA within histidylated glycol chitosan (GC-His).
- Assessment of siRNA uptake, cellular localization, and gene silencing efficacy.
Main Results:
- GC-His encapsulation significantly increased siRNA uptake (twofold) compared to controls.
- Nanoparticles localized in the cytoplasm, indicating efficient endosomal escape facilitated by histidine.
- A 64% reduction in MDM2 protein expression was observed 24 hours post-transfection with GC-His/siRNA, outperforming commercial reagents.
Conclusions:
- GC-His/siRNA-quantum dot nanoplexes are effective multifunctional vehicles for gene therapy.
- The developed system enhances siRNA stability, cellular uptake, and therapeutic gene silencing.
- This nanoplex system shows significant potential for advancing gene inhibitory therapies.
More Related Videos
Related Concept Videos
02:30siRNA - Small Interfering RNAs
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
02:15Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...